From collected data on variable region sequences of heavy chains of immunoglobulins, the probability of random associations of any two amino-acid residues in the complementarity-determining segments was computed, and pairs of residues occurring significantly more frequently than expected were selected by computer. Studies by x-ray crystallography (1-5) have established that the antibody combining site is formed by the three segments of the light chain (6) and the three corresponding segments of the heavy chain (7, 8) , shown statistically to have a high degree of variability (hypervariable regions) and predicted (6) to be the complementarity-determining segments, only some residues of which would make contact with the antigenic determinants. These findings also accord well with data from affinity labeling (9). To map antibody combining sites more precisely by locating residues within these complementarity-determining regions that contact the antigenic determinant would be an important step in understanding the specificity of antibodies, since it will manifestly be impossible to sequence and to study by x-ray crystallography a sufficient number of antibodies to establish directly the nature of all kinds of sites. For this problem, predictive methods become of great significance for, if they can be verified by experiment, they may substantially shorten the time necessary to understand the structures of antibody combining sites. Several attempts are under way to construct sites of myeloma antibodies of various specificities using the information obtained from those sites whose three-dimensional structure has been established (10).
of random associations of any two amino-acid residues in the complementarity-determining segments was computed, and pairs of residues occurring significantly more frequently than expected were selected by computer. Significant associations between Phe 32 and Tyr 33, Phe 32 and Glu 35, and Tyr 33 and Glu 35 were found in six proteins, all of which were mouse myeloma proteins which bound phosphorylcholine (= phosphocholine). From the x-ray structure of McPC603, Tyr 33 and Glu 35 are contacting residues; a seventh phosphorylcholine-binding mouse myeloma protein also contained Phe 32 and Tyr 33 but position 35 had only been determined as Glx and thus this position had not been selected. Met 34 occurred in all seven phosphorylcholine-binding myeloma proteins but was also present at this position in 29 other proteins and thus was not selected; it is seen in the x-ray structure not to be a contacting residue. The role of Phe 32 is not obvious but it could have some conformational influence. A human phosphorylcholine-binding myeloma protein also had Phe, Tyr, and Met at positions 32, 33, and 34, but had Asp instead of Glu at position 35 and showed a lower binding constant. The ability to use sequence data to locate residues in complementarity-determining segments making contact with antigenic determinants and those playing essentially a structural role would contribute substantially to the understanding of antibody specificity. Studies by x-ray crystallography (1) (2) (3) (4) (5) have established that the antibody combining site is formed by the three segments of the light chain (6) and the three corresponding segments of the heavy chain (7, 8) , shown statistically to have a high degree of variability (hypervariable regions) and predicted (6) to be the complementarity-determining segments, only some residues of which would make contact with the antigenic determinants. These findings also accord well with data from affinity labeling (9) .
To map antibody combining sites more precisely by locating residues within these complementarity-determining regions that contact the antigenic determinant would be an important step in understanding the specificity of antibodies, since it will manifestly be impossible to sequence and to study by x-ray crystallography a sufficient number of antibodies to establish directly the nature of all kinds of sites. For this problem, predictive methods become of great significance for, if they can be verified by experiment, they may substantially shorten the time necessary to understand the structures of antibody combining sites. Several attempts are under way to construct sites of myeloma antibodies of various specificities using the information obtained from those sites whose three-dimensional structure has been established (10).
It is apparent that within the complementarity-determining segments residues might be of several kinds: (1) those 617 whose side chains are in contact with the antigenic determinant and each of which contributes in part to the binding energy of the antigen-antibody interaction; (2) those residues which essentially fulfill a structural role, i.e., whose side chains are not involved in contacting the antigenic determinant; (3) residues which may not be in contact with the antigenic determinant but which may exert a conformational influence on contacting residues and are thus essential to the specificity; (4) residues involved in idiotypic specificity or idiotypic cross reactivity.
We have been systematically accumulating and storing in the PROPHET System (11) available amino-acid sequences of the variable region of immunoglobulins and have complete data on 39 first, 25 second, and 21 third complementarity-determining segments of heavy chains including human and mouse myeloma proteins with and without known antibody specificity and of various rabbit antibodies.
From such data it is possible to ask whether certain pairs of residues at any two positions in the three complementarity-determining segments occurred more frequently than expected by chance. It is evident that if all pairs of residues are compared, associations involving two, three, and four or more residues may emerge. Such associations, if they can be correlated with the specificity of myeloma proteins or antibodies, may indicate that the residues are either contacting or may play a conformationally important role in the antibody combining site.
The probability of residues at any two positions in the complementarity-determining regions of the heavy chains (31 to 35, 50 to 65, and 95 to 102 with insertions possible at 35A and 35B, 52A, 52B and 52C and 100A to 100H) being associated by chance was computed from the number of different amino acids and their frequencies at each position. Thus, for example, the amino acids at positions 32, 33, 34, and 35 in the data bank are given in Table 1 (16, II) . MOPC47A (17) , which has been sequenced only to residue 34, contains the sequence Tyr 32, Tyr 33, Met 34 and it would be of interest to establish whether or not it binds phosphorylcholine; this might permit evaluation of the possible conformational role of Phe 32. It should be mentioned that Asx 31 was also selected in all instances; its role remains uncertain, but it is a surface residue and could also be of importance conformationally. If all the phosphorylcholinebinding myeloma proteins do not contain one of the alternatives, it could be of importance to idiotypic specificity. The human myeloma contains Asp at position 31. The variabilities (6) at positions 31, 32, 33, and 35 are 33, 25, 47, and 72, respectively, while position 34 has a variability of only 9, suggesting that within a complementarity-determining segment the highest variabilities are at positions involving contacting or conformationally important residues.
Binding constants Ka of five phosphorylcholine-binding mouse (18) Since all the mouse proteins contained the same sequence for residues 32 to 35, these residues could not be responsible for differences in Ka. However, the lower Ka of the human myeloma protein would be expected from the replacement of contacting Glu 35 by Asp.
Residues selected in the second complementarity-determining segment showed a more complicated picture requiring further study. However, the contacting residues (2) Arg 52 and Glx 58 [61 in reference 19; recently shown to be Glu in three of the proteins, including McPC603 (19)] were selected along with other residues.
The sequence Phe-Tyr-Met-Glu was found only in the heavy chains of phosphorylcholine-binding myeloma proteins and did not occur in any portion of the entire variable region of 165 heavy and 373 light chains for which complete and partial sequences were available. The closest sequences found were Phe-Tyr-Thr-Glu at positions 58 to 61 and AlaTyr-Met-Glu at positions 78 to 81 of the heavy chains of proteins MU (20) and EU (21), respectively, neither known to have antibody activity.
It should be emphasized that the basis for selection of the residues in the phosphorylcholine-binding myeloma was essentially that the residues at other positions were not unique to, phosphorylcholine-binding myeloma proteins but also occurred in numerous other proteins which presumably did not bind phosphorylcholine and thus, like Met 34, were not complementarity-determining. The program also selected numerous pairs of residues in other myeloma proteins and antibodies which require further study. These other associations cannot at present be test-Proc. Nat. Acad. Sci. USA 73 (1976) ed by reference to the x-ray structure. It should be emphasized that the ability to predict will depend upon the availability of a sufficient number of sequences of all kinds so that random associations may be computed with a reasonable degree of confidence. The procedure may also prove useful in locating residues in the complementarity-determining segments associated with cross idiotypic specificity.
It is perhaps fortunate that a substantial number of variable region sequences were determined on human and mouse myeloma proteins that were not known to possess antibody activity, since these data may have more closely approximated the random set of sequences needed. More sequencing is now directed to myeloma proteins and antibodies of one or another specificity and to antibodies in species such as the rabbit for which myeloma proteins are not available. Those sequences which have been reported are all on antibodies to the pneumococcal type-specific and streptococcal group-specific polysaccharides. As additional diverse sequences are accumulated, this method can be further evaluated.
